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Estudo de associação entre polimorfismos funcionais do gene do TNF-alfa  
e transtorno obsessivo-compulsivo
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Selma A. Palácios3, Andrea H. Marques1, Homero Vallada1, Eurípedes Constantino Miguel1, Luiza 
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The obsessive-compulsive disorder (OCD) is character-
ized by recurrent unwanted thoughts (obsessions), usually ac-
companied by repetitive behaviors (compulsions) intended to 
alleviate the anxiety caused by obsessions. OCD is a relatively 
common disorder, with a lifetime prevalence of 2 to 3%1.
There is solid evidence for the involvement of genetic fac-
tors in the etiology of OCD. Although once thought to be pri-
marily psychological in origin, there is now compelling evi-
dence from twin and family studies that OCD has a genetic 
background. However, the identification of environmental and 
genetic susceptibility factors remains an open field for research. 
The immune system is one of the interfaces between the envi-
ronment and the central nervous system (CNS), justifying the 
researches on cytokines and their genetic determinants2. 
The role of the immune system in CNS processes has long 
been under investigation in the pathogenesis of a variety of neu-
ropsychiatric disorders, such as depression, dementia, and schizo-
phrenia3. Several immune parameters have also been investigated 
in some anxiety disorders, such as post-traumatic stress disorder, 
panic disorder, social phobia, and OCD4. Recent reports have sug-
gested that pro-inflammatory cytokines, like the tumor necrosis 
factor-alpha (TNFA), are involved in OCD pathophysiology5.
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ABStrAct
Obsessive-compulsive disorder (OCD) is a prevalent psychiatric disorder of unknown etiology. However, there is some evidence that the im-
mune system may play an important role in its pathogenesis. In the present study, two polymorphisms (rs1800795 and rs361525) in the pro-
moter region of the cytokine tumor necrosis factor-alpha (TNFA) gene were genotyped in 183 OCD patients and in 249 healthy controls. The 
statistical tests were performed using the PLINK® software. We found that the A allele of the TNFA rs361525 polymorphism was significantly 
associated with OCD subjects, according to the allelic χ2 association test (p=0.007). The presence of genetic markers, such as inflammatory 
cytokines genes linked to OCD, may represent additional evidence supporting the role of the immune system in its pathogenesis. 
Key words: cytokines, genetic markers, mental disorder, polymorphism.
reSUMO
O transtorno obsessivo-compulsivo (TOC) é um quadro psiquiátrico de prevalência considerável na população e de etiologia desconhecida. 
No entanto, há evidências de que o sistema imunológico pode desempenhar um papel importante em sua patogênese. No presente estudo, 
dois polimorfismos (rs1800795 e rs361525), localizados na região promotora do gene que codifica a citocina conhecida como fator de ne-
crose tumoral alfa (TNFA), foram genotipados em 183 pacientes com TOC e 249 controles saudáveis. Os testes estatísticos foram realizados 
utilizando-se o software PLINK®. Assim, evidenciou-se que o alelo A do polimorfismo rs361525 apresentava associação estatisticamente 
significante com o TOC (p=0,007). A presença de marcadores genéticos, tais como genes que codificam citocinas inflamatórias, associados 
com TOC, confere suporte adicional ao papel do sistema imunológico na patogênese desse transtorno.
Palavras-Chave: citocinas, marcadores genéticos, transtorno mental, polimorfismo.
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Although cytokines are large soluble peptides, studies 
have identified several mechanisms by which cytokines en-
ter and stimulate the brain. They act directly on the CNS by 
crossing certain regions at the blood-brain barrier, both pas-
sively (circumventricular organs, subfornical organ and area 
postrema) and via active transportation. In addition, cytok-
ines can act indirectly by signaling the brain via stimulation 
of visceral (vagal) afferents, which are projected to the tractus 
solitarius nucleus in the brainstem. Finally, cytokines can also 
act on endothelial cells of brain vasculature or glia cells in the 
circumventricular organs inducing synthesis and release of 
secondary messengers, such as central cytokines, prostaglan-
dins, and nitric oxide6. Furthermore, some studies have shown 
that there is also release of pro-inflammatory cytokines (IL-1, 
IL-6, and TNFA) by neurons and glia cells inside the CNS7. 
In recent years, the discovery of multiple functions of cy-
tokines in the CNS suggests that they play a central role in 
complex CNS functions such as cognition and memory. In 
addition, cytokines may act as immune stressors, causing 
neurochemical changes and activating other pathways that 
can influence intracellular, apoptotic and oxidative mecha-
nisms, which might contribute to mood and anxiety-related 
disorders5.
TNFA is a cytokine that has been investigated in neuropsy-
chiatric disorders, due to its effects on the CNS. It is produced 
by macrophages and circulating monocytes and glia cells, 
playing an important role in a variety of infectious, inflamma-
tory, and autoimmune conditions as well as in synaptic plas-
ticity8. Studies have demonstrated that cytokine production 
during the inflammatory process can lead the brain to develop 
neurochemical, neuroendocrine, neuroimmune, and behavior-
al changes9. Taking all these data into account, polymorphisms 
in genes that codify for cytokines, especially TNFA, are poten-
tial candidates to explain the OCD pathophysiology.
Although several reports have focused on the role of cytok-
ines in OCD, this is still not completely elucidated. Cytokine 
studies in OCD patients have shown contradictory results, 
from increase in type-I cytokines in cerebrospinal fluid and 
in their plasma levels to either decrease of natural killer (NK) 
activity and pro-inflammatory cytokines levels or lack of 
alterations5.
TNFA gene polymorphisms have been studied in sever-
al neuropsychiatric disorders, such as Alzheimer’s disease, 
schizophrenia, and depression. However, there are few stud-
ies investigating the relationship between polymorphisms in 
cytokine genes and OCD patients. A previous case-control 
study from the authors of this article found a significant asso-
ciation between the TNFA -308 and -238 G/A polymorphisms 
and OCD10. We have also investigated a polymorphism in the 
nuclear factor of kappa light polypeptide gene enhancer in 
B-cells inhibitor-like 1 – NFKBIL1 (rs2071592) – in another 
case-control study, finding no association between that poly-
morphism and OCD11.
Thus, in the present paper we investigated polymor-
phisms in the gene that codifies for the cytokine TNFA, us-
ing a case-control approach in a larger sample than the one 
used in the former paper from our group, hoping to validate 
the present findings.
MetHODS
Sample
All patients from our dataset who met DSM-IV crite-
ria for OCD were included in the study. Miguel et al. made 
a detailed description of the ascertainment12. Briefly, OCD 
patients were recruited through the Obsessive-Compulsive 
Spectrum Disorders Program (PROTOC at University of São 
Paulo). The final sample consisted of 183 OCD patients and 
249 healthy controls. In the present study, 111 subjects from 
the previous investigation were included in the analysis10. 
Informed consents approved by the local ethical committee 
were signed by all participants. The project was approved by 
the Institutional Review Board of University of São Paulo. 
Genotyping
Venous blood samples were collected in anticoagulant 
(EDTA) 5 mL tubes. Genomic DNA was extracted accord-
ing to standard protocols. The genotyping of the TNFA -308 
(rs1800629) and -238 G/A (rs361525) polymorphisms was 
performed using a PCR- restriction fragment length poly-
morphism assay, as described by Ramasawmy et al.13.
Statistical analysis
Deviation from Hardy-Weinberg equilibrium (HWE) was 
tested separately in healthy controls and patients by using 
the PLINK® software14. The association test was also per-
formed using PLINK®. To reduce the odds of false-positive 
findings, permutation analysis with 100,000 permutations 
was performed.
reSUltS
Allele frequencies and genotypic distribution of the poly-
morphisms were in the HWE (patients: p=0.7385; controls: 
p=0.14) regarding the rs1800629 in both groups, as well as the 
rs361525 in the Control Group (p=0.22). The rs361525 marker 
in the Case Group was out of the HWE (p=0.0004).
The A allele (adenine, the minor allele) of the TNFA 
rs361525, which has a frequency of 0.054, was significantly 
associated with OCD subjects according to the allelic χ2 as-
sociation test (p=0.007), as can be seen in Table. The major 
allele in this single nucleotide polymorphism (SNP) is a gua-
nine (G). The results remained significant after the 100,000 
permutation analysis (p=0.004).
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DiScUSSiON
In this study we investigated if there were associations 
between two markers on the TNFA gene with OCD subjects, 
using the allelic χ2 association test. We found a significant 
association between the A allele of the TNFA rs361525 and 
OCD subjects, which persisted after 100,000 permutations 
(permuted p=0.03). This result is a replication of the findings 
by Hounie et al.10 in an expanded sample, supporting an as-
sociation between TNFA and OCD.
It has been suggested that the polymorphisms investigated 
in the present paper affect TNFA transcription. Studies with 
both positive15,16 and negative17-19 findings investigating TNFA 
polymorphisms and their transcription have been published20-24. 
However, it has been reported that TNFA plasma levels vary 
with age, body mass index, gender, time of the day, medicine 
intake, and several other factors5. Additionally, changes in be-
havior may probably be related to the ones in the CNS through 
local production of cytokines and not through plasma levels25. 
Consequently, it is not surprising that studies investigating the 
relationship between OCD and cytokine plasma levels have in-
consistent results, and the polymorphisms found in this study 
to be associated with OCD may not be sufficient to explain 
TNFA plasma levels, which are the results of a complex chain 
of interconnected genetic and environmental factors.
It is still unclear how cytokines mediate OCD or oth-
er psychiatric/neurological symptoms. In an animal model 
of cytokine-mediated cognitive functions, such as memory 
and learning, it has been demonstrated that the presence of 
TNFA under immunologically non-challenged conditions is 
essential for the normal functioning of memory and learning. 
The literature demonstrates that cytokines can profoundly 
affect the metabolism of serotonin, norepinephrine, and do-
pamine26. It appears to be of significance the ability of the im-
mune system to activate the indolamine-2,3-dehydrogenase 
enzyme. It breaks down tryptophan and can influence sero-
toninergic neurotransmission27. Besides, serotonin reuptake 
inhibitors and a polymorphism in the serotonin transporter 
gene that affects monoamine metabolism have been shown 
to influence the development of cytokine-induced depres-
sive-like behavior in laboratory animals and in humans28. 
The potential clinical application of the association be-
tween inflammation and depression is that inflammatory 
biomarkers may identify depressed patients, who are less 
likely to respond to conventional antidepressant treatment 
and might provide an indicator of treatment response29,30. 
The present investigation has some limitations. The 
small sample size can raise the odds of false-negative results. 
However, this study replicated in a larger sample the results 
from a previous study10. It is also somewhat concerning that 
the Case Group was not in HWE for the rs361525. On the 
other hand, deviations from the HWE can be very informa-
tive. In control subjects, deviations could indicate that one 
or more of the model assumptions have been violated or that 
a genotyping error has occurred. In case subjects, deviation 
from HWE, assuming that sources of error have been elimi-
nated, may indicate the association of a locus with disease. 
As the HWE deviation was exclusive to the affected sample, 
herein, this could be explained by a “selection of risk alleles” 
in the Case Group.
Investigations conducted in highly admixed ethnicity 
populations, such as the Brazilian, may bring problems re-
garding ethnical stratification11. In conclusion, the results 
of the present investigation provide evidence for the asso-
ciation between the TNFA polymorphism and OCD in the 
Brazilian sample. Furthermore, it is always possible that 
these polymorphisms are in linkage disequilibrium with 
non-identified genes, which are in fact those contributing 
to the pathogenesis of OCD or even with other polymor-
phisms within the TNFA. Our results suggest that the evalu-
ation of this gene is important to clarify its role in the OCD 
development. More comprehensive polymorphism cover-
age within the TNFA using high-throughput sequence of 
the entire gene is warranted. However, to confirm the as-
sociation of the TNFA polymorphism with OCD, further 
studies must be conducted focusing on ethnical aspects. 
Moreover, differences in association of the TNFA polymor-
phism and OCD, found in different investigations, could be 
clarified by the analysis of larger case-control studies, addi-
tional family-based studies, and especially linkage disequi-
librium mapping of TNFA, which should be considered a 
high-priority gene given its potentially important influence 
on the risk for OCD.
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TNFA: tumor necrosis factor-alpha; OCD: obsessive-compulsive disorder; SNP: single nucleotide polymorphism; FA: frequency of minor allele in cases; FU: frequency 
of minor allele in controls; p-value: asymptotic p-value for this test; OR: estimated odds ratio (for minor allele, i.e. major allele is reference); *:significant results.
SNP Position Minor Allele FA FU χ2 p OR
s1800629 31651010 A 0.123 0.09 2.094 0.1479 1.377
rs361525 31651080 A 0.085 0.03 11.33 0.007* 2.788
Table. Allelic χ2 association test for TNFA single markers in OCD subjects.
90 Arq Neuropsiquiatr 2012;70(2):87-90
1. Weissman MM, Bland RC, Canino GJ, et al. The cross national 
epidemiology of obsessive compulsive disorder. The Cross National 
Collaborative Group. J Clin Psychiatry 1994;55:5-10.
2. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis 
of the genetic epidemiology of anxiety disorders. Am J Psychiatry 
2001;158:1568-1578.
3. García-Bueno B, Caso JR, Leza JC. Stress as a neuroinflammatory 
condition in brain: damaging and protective mechanisms. Neurosci 
Biobehav Rev 2008;32:1136-1151.
4. Maes M, Lin AH, Delmeire L, et al. Elevated serum interleukin-6 (IL-6) 
and IL-6 receptor concentrations in posttraumatic stress disorder 
following accidental man-made traumatic events. Biol Psychiatry 
199;45:833-839.
5. Konuk N, Tekin IO, Ozturk U, et al. Plasma levels of tumor necrosis 
factor-alpha and interleukin-6 in obsessive compulsive disorder. 
Mediators Inflamm 2007;2007:1-5.
6. Silverman MN, Pearce BD, Biron CA, Miller AH. Immune modulation of 
the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. 
Viral Immunol 2005;18:41-78.
7. Szelényi J, Vizi ES. The catecholamine cytokine balance: interaction 
between the brain and the immune system. Ann N Y Acad Sci 
2007;1113:311-324.
8. Vassalli P. The pathophysiology of tumor necrosis factors. Ann Rev 
Immunol 1992;10:411-452.
9. Licinio J, Wong ML. The role of inflammatory mediators in the 
biology of major depression: central nervous system cytokines 
modulate the biological substrate of depressive symptoms, regulate 
stress-responsive systems, and contribute to neurotoxicity and 
neuroprotection. Mol Psychiatry 1999;4:317-327.
10. Hounie AG, Cappi C, Cordeiro Q, et al. TNF-alpha polymorphisms 
are associated with obsessive-compulsive disorder. Neurosci Lett 
2008;442:86-90.
11. Cordeiro Q, Cappi C, Sampaio AS, et al. Association study between the 
-62A/T NFKBIL1 polymorphism and obsessive-compulsive disorder. 
Rev Bras Psiquiatr 2009;31:131-135.
12. Miguel EC, Ferrão YA, Rosário MCD, et al. The Brazilian Research 
Consortium on Obsessive-Compulsive Spectrum Disorders: 
recruitment, assessment instruments, methods for the development 
of multicenter collaborative studies and preliminary results. Rev Bras 
Psiquiatr 2008;30:185-196.
13. Ramasawmy R, Faé KC, Spina G, et al. Association of polymorphisms 
within the promoter region of the tumor necrosis factor-alpha with 
clinical outcomes of rheumatic fever. Mol Immunol 2007;44:1873-1878.
14. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-
genome association and population-based linkage analyses. Am J 
Hum Genet 2007;81:559-575.
15. Abraham LJ, Kroeger KM. Impact of the -308 TNF promoter 
polymorphism on the transcriptional regulation of the TNF gene: 
relevance to disease. J Leukoc Biol 1999;66:562-566.
16. Sallakci N, Akcurin G, Köksoy S. TNF-alpha G-308A polymorphism is 
associated with rheumatic fever and correlates with increased TNF-
alpha production. J Autoimmun 2005;25:150-154.
17. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. 
Relevance of the tumor necrosis factor alpha (TNF alpha) -308 
promoter polymorphism in TNF alpha gene regulation. J Inflamm 
1995;46:32-41.
18. Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A. 
Genetic influence on cytokine production in meningococcal disease. 
Lancet 1997;349:1912-1913.
19. Uglialoro AM, Turbay D, Pesavento PA, et al. Identification of three 
new single nucleotide polymorphisms in the human tumor necrosis 
factor-alpha gene promoter. Tissue Antigens 1998;52:359-367.
20. Drouet C, Shakhov AN, Jongeneel CV. Enhancers and transcription 
factors controlling the inducibility of the tumor necrosis factor-alpha 
promoter in primary macrophages. J Immunol 1991;147:1694-1700.
21. Fong CL, Siddiqui AH, Mark DF. Identification and characterization of 
a novel repressor site in the human tumor necrosis factor alpha gene. 
Nucleic Acids Res 1994;22:1108-1114.
22. Pociot F, D’Alfonso S, Compasso S, Scorza R, Richiardi PM. Functional 
analysis of a new polymorphism in the human TNF alpha gene 
promoter. Scand J Immunol 1995;42:501-504.
23. Kaluza W, Reuss E, Grossmann S, et al. Different transcriptional 
activity and in vitro TNF-alpha production in psoriasis patients 
carrying the TNF-alpha 238A promoter polymorphism. J Invest 
Dermatol 2000;114:1180-1183.
24. Bayley JP, de Rooij H, van den Elsen PJ, Huizinga TW, Verweij CL. 
Functional analysis of linker-scan mutants spanning the -376, -308, 
-244, and -238 polymorphic sites of the TNF-alpha promoter. Cytokine 
2001;14:316-323.
25. Sawada M, Imamura K, Nagatsu T. Role of cytokines in inflammatory 
process in Parkinson’s disease. J Neural Transm 2006;70:373-381.
26. McEwen BS. Physiology and neurobiology of stress and adaptation: 
central role of the brain. Physiol Rev 2007;87:873-904.
27. Kohl C, Sperner-Unterweger B. IDO and clinical conditions associated 
with depressive symptoms. Curr Drug Metab 2007;8:283-287.
28. Mössner R, Mikova O, Koutsilieri E, et al. Consensus paper of the 
WFSBP Task Force on Biological Markers: biological markers in 
depression. World J Biol Psychiatry 2007;8:141-174.
29. Jun T, Pae C, Chae J, et al. Possible association between -G308A tumour 
necrosis factor-alpha gene polymorphism and major depressive 
disorder in the Korean population. Psychiatr Genet 2003;13:179-181.
30. Miller AH. Norman Cousins Lecture. Mechanisms of cytokine-induced 
behavioral changes: psychoneuroimmunology at the translational 
interface. Brain Behav Immun 2009;23:149-158.
references
